About Nuvanta Life Sciences
Nuvanta Life Sciences is a Healthcare company. Pharmaceutical products development and provision of affordable medicines in India. The company has 14 employees. Its Indian entity Nuvanta Life Sciences Private Limited reported revenue of ₹1.48 Cr. Nuvanta Life Sciences offers products and services including Cynomega Plus and Ptoxy-ER 400. Its focus areas include Pharmaceuticals, Drug Manufacturing, Medicines Development and Distribution.
Company details
High-quality and affordable medicines are provided by Nuvanta Life Sciences Private Limited, which has been built on a foundation of care to support patients in need across geographies. A mission to discover and market pharmaceutical products for disease prevention and cure is pursued, along with a vision to achieve leadership in India and globally through innovative solutions and ethical practices. Responsibility to society is emphasized, with commitments to excellence, customer satisfaction, and empowered employees driving operations. New paths are considered to bring value to the healthcare community and patients families.
- Employees 14
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website nuvantalife.com
- Legal Name Nuvanta Life Sciences Private Limited
- Date of Incorporation 10 Dec, 2020
- Jurisdiction Ahmedabad, Gujarat, India
- Indian entity revenue₹1.48 Cr
FY 2024 · -2% YoY
- Indian entity net loss-₹36.8 Lakh
FY 2024 · -25% margin
- Indian entity EBITDA-₹29.1 Lakh
FY 2024 · -20% margin
- Employee Count14
Associated legal entities of Nuvanta Life Sciences
Nuvanta Life Sciences operates through Nuvanta Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nuvanta Life Sciences Private Limited CIN U24230GJ2020PTC118775 | Active | 10 Dec 2020 | Ahmedabad, Gujarat | ₹1.5 Cr | 14 | 2 | View details |
Products & Services of Nuvanta Life Sciences
Nuvanta Life Sciences offers a comprehensive portfolio of products and services, including Cynomega Plus and Ptoxy-ER 400.
Omega 3, 6, and 9 Fatty Acids along with Tocotrienols are included in soft gelatin capsules that are provided for health support
Pentoxifylline Extended Release Tablets are offered at 400 mg for circulatory health needs
Board of directors of Nuvanta Life Sciences Private Limited (Nuvanta Life Sciences)
Nuvanta Life Sciences Private Limited is the primary company behind Nuvanta Life Sciences. The board of Nuvanta Life Sciences Private Limited currently have 2 directors; the longest-serving is Maulik Indravadanbhai Soni, appointed in 2022. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Maulik Indravadanbhai Soni DIN 07934127 | Managing Director | 26 May 2022 | 4 yrs 5 mo | Nuvanta Life Sciences Private Limited |
| Anjana Maulik Soni DIN 10265137 | Director | 11 Aug 2023 | 3 yrs 2 mo | Nuvanta Life Sciences Private Limited |
Financials of Nuvanta Life Sciences
Figures of Nuvanta Life Sciences Private Limited, the primary company behind Nuvanta Life Sciences, for FY 2024. Revenue was ₹1.48 Cr (-2% year on year). Net loss was -₹36.8 Lakh (-25% margin). EBITDA was -₹29.1 Lakh (-20% margin). Revenue has grown at a compounded annual rate of +922% over three years.
- ₹1.48 CrRevenue · FY 2024 · -2% YoY
- -₹36.8 LakhNet loss · -25% margin
- -₹29.1 LakhEBITDA · -20% margin
- ₹1 LakhPaid-up capital
- 14Employees (provident fund records)
- +922%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Nuvanta Life Sciences Private Limited are on its company page.
Detailed financial statements for Nuvanta Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nuvanta Life Sciences
Nuvanta Life Sciences has 14 employees.
The primary company behind Nuvanta Life Sciences, Nuvanta Life Sciences Private Limited, reported revenue of ₹1.48 Cr for FY 2024, down 2% year on year.
High-quality and affordable medicines are provided by Nuvanta Life Sciences Private Limited, which has been built on a foundation of care to support patients in need across geographies. A mission to discover and market pharmaceutical products for disease prevention and cure is pursued, along with a vision to achieve leadership in India and globally through innovative solutions and ethical practices. Responsibility to society is emphasized, with commitments to excellence, customer satisfaction, and empowered employees driving operations. New paths are considered to bring value to the healthcare community and patients families.
Nuvanta Life Sciences offers Cynomega Plus and Ptoxy-ER 400.
Nuvanta Life Sciences operates through Nuvanta Life Sciences Private Limited.
The legal entities of Nuvanta Life Sciences currently have 2 directors, including Anjana Maulik Soni, Maulik Indravadanbhai Soni.